Skip to main content
. 2012 Jul 28;15(4):623–641. doi: 10.1007/s10456-012-9291-z

Fig. 6.

Fig. 6

Effect of sunitinib on tumour cell viability. a The ability of 4T1 tumour cells, RENCA tumour cells or primary endothelial cells (HUVECs), to proliferate in the presence of sunitinib was measured in vitro. Graphs show the surviving fraction of cells after 72 h ± SEM